| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 90/09/28 | 102/12/25 | 陳佩君 | 陳佩君 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| -0.82(Q2) | 0 | 2.89 | 0% |
| 實收資本額 | 已發行普通股 | ||
| 2,057,615,000 | 205,761,500 | ||
| 主要經營業務 | |||
| CMC技術及cGMP生產技術平台提供業界新藥開發及GMP製造的服務 | |||
| 公司網址 | |||
| mycenax.com.tw | |||
永昕(4726) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 51,157 | 71,812 | 185.1% | -28.8% | 425,538 | 460,090 | -7.5% |
| 2023/07 | 17,944 | 11,132 | -48.3% | 61.2% | 374,381 | 388,278 | -3.6% |
| 2023/06 | 34,713 | 21,663 | -66.9% | 60.2% | 356,437 | 377,146 | -5.5% |
| 2023/05 | 104,828 | 76,628 | 33.5% | 36.8% | 321,724 | 355,483 | -9.5% |
| 2023/04 | 78,508 | 53,306 | 80.2% | 47.3% | 216,896 | 278,855 | -22.2% |
| 2023/03 | 43,559 | 150,581 | -40.5% | -71.1% | 138,388 | 225,549 | -38.6% |
| 2023/02 | 73,180 | 54,336 | 238% | 34.7% | 94,829 | 74,968 | 26.5% |
| 2023/01 | 21,649 | 20,632 | -78.8% | 4.9% | 21,649 | 20,632 | 4.9% |
| 2022/12 | 102,170 | 97,524 | 88.2% | 4.8% | 732,276 | 774,270 | -5.4% |
| 2022/11 | 54,301 | 33,443 | 37.8% | 62.4% | 630,106 | 676,746 | -6.9% |
| 2022/10 | 39,397 | 89,927 | -48.4% | -56.2% | 575,804 | 643,303 | -10.5% |
| 2022/09 | 76,317 | 82,832 | 6.3% | -7.9% | 536,407 | 553,376 | -3.1% |
| 2022/08 | 71,812 | 48,430 | 545.1% | 48.3% | 460,090 | 470,544 | -2.2% |
| 2022/07 | 11,132 | 23,165 | -48.6% | -51.9% | 388,278 | 422,114 | -8% |
| 2022/06 | 21,663 | 22,143 | -71.7% | -2.2% | 377,146 | 398,950 | -5.5% |
| 2022/05 | 76,628 | 51,512 | 43.8% | 48.8% | 355,483 | 376,807 | -5.7% |
| 2022/04 | 53,306 | 33,077 | -64.6% | 61.2% | 278,855 | 325,294 | -14.3% |
| 2022/03 | 134,113 | 80,289 | 146.8% | 67% | 209,081 | 292,217 | -28.5% |
| 2022/02 | 54,336 | 25,572 | 163.4% | 112.5% | 74,968 | 211,928 | -64.6% |
| 2022/01 | 20,632 | 186,356 | -77.9% | -88.9% | 20,632 | 186,356 | -88.9% |
| 2021/12 | 93,529 | 48,731 | 179.7% | 91.9% | 770,275 | 665,341 | 15.8% |
| 2021/11 | 33,443 | 28,503 | -62.8% | 17.3% | 676,746 | 616,610 | 9.8% |
| 2021/10 | 89,927 | 100,959 | 8.6% | -10.9% | 643,303 | 588,107 | 9.4% |
| 2021/09 | 82,832 | 69,147 | 71% | 19.8% | 553,376 | 487,148 | 13.6% |
| 2021/08 | 48,430 | 52,980 | 109.1% | -8.6% | 470,544 | 418,001 | 12.6% |
| 2021/07 | 23,165 | 26,188 | 4.6% | -11.5% | 422,114 | 365,021 | 15.6% |
| 2021/06 | 22,143 | 169,149 | -57% | -86.9% | 398,950 | 338,833 | 17.7% |
| 2021/05 | 51,512 | 47,287 | 55.7% | 8.9% | 376,807 | 169,684 | 122.1% |
| 2021/04 | 33,077 | 52,536 | -58.8% | -37% | 325,294 | 122,397 | 165.8% |
| 2021/03 | 80,289 | 33,977 | 214% | 136.3% | 292,217 | 69,861 | 318.3% |
| 2021/02 | 25,572 | 30,210 | -86.3% | -15.4% | 211,928 | 35,884 | 490.6% |
| 2021/01 | 186,356 | 5,674 | 202.4% | 3184.4% | 186,356 | 5,674 | 3184.4% |
| 2020/12 | 61,631 | 43,173 | 116.2% | 42.8% | 678,241 | 390,844 | 73.5% |
| 2020/11 | 28,503 | 70,956 | -71.8% | -59.8% | 616,610 | 347,671 | 77.3% |
| 2020/10 | 100,959 | 17,345 | 46% | 482.1% | 588,107 | 276,715 | 112.5% |
| 2020/09 | 69,147 | 30,736 | 30.5% | 125% | 487,148 | 259,370 | 87.8% |
今展科(6432) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 7.45% | -1.65% | 2020Q3 | 11.36% | 6.82% |
| 2023Q1 | 5.06% | -9.95% | 2020Q2 | 19.32% | 4.61% |
| 2022Q4 | -1.05% | -8.27% | 2020Q1 | -4.95% | 1.56% |
| 2022Q3 | -15.72% | -7.80% | 2019Q4 | 1.49% | 2.05% |
| 2022Q2 | -21.19% | -7.06% | 2019Q3 | 3.20% | -1.79% |
| 2022Q1 | 6.67% | 3.83% | 2019Q2 | 7.21% | -0.93% |
| 2021Q4 | -1.41% | 3.23% | 2019Q1 | -3.52% | -1.57% |
| 2021Q3 | -10.92% | 2.91% | 2018Q4 | -12.39% | 0.21% |
| 2021Q2 | 25.01% | 9.37% | 2018Q3 | 6.34% | 2.99% |
| 2021Q1 | 4.37% | 7.08% | 2018Q2 | 4.07% | 3.72% |
| 2020Q4 | -3.35% | 5.08% | 2018Q1 | 4.07% | 3.88% |
評論0